Tongxinluo Capsule in Ischemic Stroke Patients(TISS)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2007 participants.
Also called NCT01919671
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,007 participants
- Sponsor
- Registry
-
NCT01919671
-
- Other papers using this trial's data
- Tongxinluo and Functional Outcomes Among Patients With Acute Ischemic Stroke: A Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01919671. Randomized; quadruple masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tongxinluo Capsule in Ischemic Stroke Patients(TISS)
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Tongxinluo capsule
- Intervention (Drug)
- placebo capsule
- Lead sponsor
- yongjun wang
Record details
- Record id
cardio:ct-nct01919671- Content hash
465707781c9e2e45113ba8ca21621286e0983cab46d5c8f661adbbff8037ee8b